Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 3, 1998, Pages 167-170

  Macias J ^a   Pineda, J A ^a   Leal, M ^a   Abad, M A ^a   Garcia Pesquera F ^a   Delgado, J ^a   Gallardo, J A ^a   Sanchez Quijano A ^a   Lissen, E ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Chronic viral hepatitis; Hepatitis C virus; Hiv 1 infection

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DELTA AGENT HEPATITIS; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FAILURE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL;

EID: 0031748118     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf01691112     Document Type: Article

References (16)

1. Horvath J, Raffanti SP: Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses. Clinical Infectious Diseases (1994) 18:339-347
2. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger FB, Gitnick G, Knodell RG, Perrillo RP, Stevens C, Hollingsworth CG: Long term mortality after transfusion-associated nonA, nonB hepatitis. New England Journal of Medicine (1992) 327: 1906-1911
3. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ: Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. Journal of Acquired Immune Deficiency Syndrome (1993) 6:602-610
4. Eysler ME, Fried MW, Di Bisceglie AM, Goedert JJ: Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Blood (1994) 84: 1020-1023
5. Sánchez-Quijano A, Andreu J, Gavilán F, Luque F, Abad MA, Soto B, Muñoz J, Aznar JM, Leal M, Lissen E: Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C. European Journal of Clinical Microbiology & Infectious Diseases (1995) 14:949-953
6. Soto B, Sánchez-Quijano A, Rodrigo L, Olmo JA, García-Bengoechea M, Hernández-Quero J, Rey C, Abad MA, Rodríguez M, Gilabert MS, González F, Mirón P, Caruz A, Relimpio F, Torronteras M, Leal M, Lissen E: Human immunodeficiency virus infection modifies the natural history of chronic parenterally acquired hepatitis C with an unusually rapid progression to cirrhosis. A multicenter study on 547 patients. Journal of Hepatology (1997) 26:1-5
7. Thomas DL, Shih JW, Alter HJ, Vlahov D, Conn S, Hoover DR, Cheung L, Nelson K: Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. Journal of Infectious Diseases (1996) 174:690-695
8. Cribier B, Rev D, Schimitt C, Lang JM, Kim A, Stoll-Keller F: High hepatitis C viremia and impaired antibody response in patients coinfected with HIV. AIDS (1995) 9: 1131-1136
9. Eyster ME, Sanders JS, Battegay M, Di Bisceglie AM: Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C. Digestive Diseases and Science (1996) 40:1583-1588
10. Soriano V, García-Samaniego J, Gutiérrez M, Bravo R, González-Lahoz J: High morbidity and mortality of chronic viral liver disease in HIV-infected individuals in Spain. Journal of Infection (1994) 104:100-101
11. Jover R, Gutiérrez A, Boix V, Portilla J: Mortalidad por enfermedad hepática crónica en pacientes con infección por VIH. Medicina Clínica (1995) 105:48
12. Weiss SH, Skurnick J, Henrard D: Mortality due to hepatic failure among a cohort of injection drug users: a preliminary report from the United States. Workshop on viral hepatitis and HIV infection. Anales de Medicina Interna (1995):57-58
13. United States Public Health Service/Infectious Diseases Society of America: United States Public Health Service/Infectious Diseases Society of America guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. Clinical Infectious Diseases (1995) 2. Supplement 1:32-43
14. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report (1992) 41 (RR-17):1-19
15. Soriano V, García-Samaniego J, Bravo R, Castro A, Odriozola PM, González J, Colmenero M, Carballo F, Suárez D, Llibre JM: Efficacy and safety of alpha-interferon for the treatment of chronic hepatitis C in HIV-infected patients. Journal of Infection (1995) 31:9-13
16. Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Posher ME, Jacobsen DM, Shaw GM, Richman DD, Volverding PA: HIV viral load markers in clinical practice. Nature Medicine (1996) 2:625-629